Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves
Circulation: Cardiovascular Interventions · 2023-12 · 16 (12)
DOI: 10.1161/circinterventions.123.013083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2023-12. Verfasst von Jingjing He und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (J.H., T.-Y.X., Y.-J.Y., Y.P., J.-F.W., Z.-G.Z., Y.-W.O., Q.L., X.W., Z.Z., H.-R.Y., K.J., Y.F., M.C.), West China Hospital,…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Heart Valve Diseases, Aortic Valve Stenosis, Stroke. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. The study aims to compare the outcomes of transcatheter aortic valve replacement for AS in patients with type 0 bicuspid, type 1 bicuspid, and tricuspid aortic valve anatomy. METHODS: We enrolled consecutive patients undergoing transcatheter aortic valve replacement for severe AS between 2012 and 2022 in this single-center retrospective cohort study. The primary outcome was mortality, while secondary outcomes included in-hospital complications such as stroke and pacemaker implantation and transcatheter heart valve hemodynamic performance. RESULTS: The number of patients with AS with type 0 bicuspid, type 1 bicuspid, and tricuspid aortic valve anatomy was 328, 302, and 642, respectively. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2% versus 1.7% versus 1.7%, P overall =0.522; 1 year: 10% versus 2.3% versus 6.2%, P overall =0.099) and all stroke (30 days: 1.0% versus 0.9% versus 0.0%, P overall =0.765; 1 year: 1.4% versus 1.6% versus 1.3%, P overall =NS) were nonsignificant, and the incidence of overall in-hospital complications was comparable among groups. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44]; P =0.035). The proportion of patients with a mean residual gradient ≥20 mm Hg was the highest in those with type 0 bicuspid anatomy, although the need for permanent pacemaker implantation was the lowest in this group. CONCLUSIONS: Major clinical outcomes of transcatheter aortic valve replacement for AS in patients with type 0 bicuspid, type 1 bicuspid, and tricuspid aortic valve anatomy are equivalent at short- and mid-term follow-up. These observations merit further exploration in prospective international registries and randomized controlled trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology (J.H., T.-Y.X., Y.-J.Y., Y.P., J.-F.W., Z.-G.Z., Y.-W.O., Q.L., X.W., Z.Z., H.-R.Y., K.J., Y.F., M.C.), West China Hospital, Sichuan University.
- Cardiology Department, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China (J.H.).
- Laboratory of Heart Valve Disease (T.-Y.X., Z.-G.Z., H.-R.Y., M.C.), West China Hospital, Sichuan University.
- Department of Anesthesiology (G.C.), West China Hospital, Sichuan University.
- Department of Cardiology, University Hospital Galway, National University of Ireland (D.M.).
- Division of Cardiology, Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada (N.P.).
ORCID-Profile: Tian-Yuan Xiong, Yong Peng, Zhen-Gang Zhao, Hao-Ran Yang, Kaiyu Jia, Mao Chen
Zitieren
APA
He, J., Xiong, T. Y., Yao, Y. J., Peng, Y., Wei, J. F., Zhao, Z. G., Chen, G., Ou, Y. W., Liu, Q., Wang, X., Zhu, Z., Yang, H. R., Jia, K., Mylotte, D., Piazza, N., Prendergast, B., Feng, Y., & Chen, M. (2023). Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves. Circulation: Cardiovascular Interventions, 16(12). https://doi.org/10.1161/circinterventions.123.013083
Vancouver
He J, Xiong TY, Yao YJ, Peng Y, Wei JF, Zhao ZG, et al. Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves. Circulation: Cardiovascular Interventions. 2023;16(12). doi:10.1161/circinterventions.123.013083
BibTeX
@article{He2023,
author = {He, Jingjing and Xiong, Tian-Yuan and Yao, Yi-Jun and Peng, Yong and Wei, Jia-Fu and Zhao, Zhen-Gang and Chen, Guo and Ou, Yuan-Weixiang and Liu, Qi and Wang, Xi and Zhu, Zhongkai and Yang, Hao-Ran and Jia, Kaiyu and Mylotte, Darren and Piazza, Nicolo and Prendergast, Bernard and Feng, Yuan and Chen, Mao},
title = {Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves},
journal = {Circulation: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {12},
doi = {10.1161/circinterventions.123.013083}
}
EUVIMED